Partnership / Contract Expansion
Earnings & Outlook
Johnson & Johnson reported Q4 2025 earnings and surpassed Wall Street expectations while projecting 2026 sales and earnings above forecasts. However, competitive pressure from Boston Scientific and Medtronic has weighed on its electrophysiology business, contributing to mixed stock performance.
Partnership / Contract Expansion
Business / Merger News
Market Analysis
Financial / Business News
